147 related articles for article (PubMed ID: 11711782)
1. Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.
van der Wouden EJ; Thijs JC; van Zwet AA; Kleibeuker JH
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1235-9. PubMed ID: 11711782
[TBL] [Abstract][Full Text] [Related]
2. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
4. Arrest of chronic acid suppressant drug use after successful Helicobacter pylori eradication in patients with peptic ulcer disease: a six-month follow-up study.
Hurenkamp GJ; Grundmeijer HG; Van Der Ende A; Tytgat GN; Assendelft WJ; Van Der Hulst RW
Aliment Pharmacol Ther; 2001 Jul; 15(7):1047-54. PubMed ID: 11421881
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
9. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication on peptic ulcer disease complicated with outlet obstruction.
Taskin V; Gurer I; Ozyilkan E; Sare M; Hilmioglu F
Helicobacter; 2000 Mar; 5(1):38-40. PubMed ID: 10672050
[TBL] [Abstract][Full Text] [Related]
11. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
12. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Helicobacter pylori eradication therapy in cirrhotic patients with peptic ulcer disease.
Mitrică D; Pleşa A; Constantinescu R; Drug V; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):367-74. PubMed ID: 21870725
[TBL] [Abstract][Full Text] [Related]
14. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
15. Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
McColl KE; el-Nujumi A; Murray LS; el-Omar EM; Dickson A; Kelman AW; Hilditch TE
Gut; 1998 May; 42(5):618-22. PubMed ID: 9659153
[TBL] [Abstract][Full Text] [Related]
16. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
[TBL] [Abstract][Full Text] [Related]
17. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori eradication prevents recurrence from peptic ulcer haemorrhage.
Vergara M; Casellas F; Saperas E; de Torres I; Lopez J; Borruel N; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 2000 Jul; 12(7):733-7. PubMed ID: 10929898
[TBL] [Abstract][Full Text] [Related]
19. An audit of low dose triple therapy for eradication of Helicobacter pylori.
Fraser AG; Moore L; Ali MR; Chua LE; Hollis B; Little SV
N Z Med J; 1996 Aug; 109(1027):290-2. PubMed ID: 8773671
[TBL] [Abstract][Full Text] [Related]
20. Eradication of helicobacter pylori among patients from a primary care practice.
Gomollón F; Gimeno L; Valdepérez J; Yus C; Marzo J; Pérez-Caballero MC
J Fam Pract; 1996 Dec; 43(6):551-5. PubMed ID: 8969702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
